This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
JCHAIN / Immunoglobulin J chain · IHC design guide
Design Immunohistochemistry for JCHAIN
Plan chromogenic JCHAIN IHC in paraffin sections using the catalog antibody at 2–5 μg/ml (datasheet A02644-2). Use the documented cytoplasmic and plasma staining pattern to guide control selection and scoring (HPA tissue IHC).
Evidence assembled Oct 2026 · For research use; verify linked source records and product datasheet before use
JCHAIN Immunohistochemistry Experimental Design Guide
Expected localisation, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
Must know before staining
| Expected localisation | Cytoplasmic staining; additional plasma positivity (HPA tissue IHC) | |
| Staining pattern | Enterocyte cytoplasm; additional plasma positivity (HPA tissue IHC) | |
| Antigen retrieval | EDTA pH 8.0 HIER, heat-mediated (datasheet A02644-2) | |
| Positive control | Appendix+4 more · see all | |
| Negative control | Adipose tissue+4 more · see all |
Important caveats
Reasons your staining may differ from the expected pattern.
| Fixation | Keep paraffin-section fixation consistent (standard IHC practice; not target-specific) | |
| Caveat | As a secreted protein, RNA and protein locations may differ (HPA tissue IHC) | |
| Regulation | Expression regulation not annotated (UniProt) | |
| Isoform / epitope | 0 annotated isoforms; signal peptide is cleaved (UniProt) |
Section 1
Recommended JCHAIN IHC & IF Protocols
The catalog antibody protocol uses EDTA retrieval (datasheet A02644-2). The published IHC options below report JCHAIN staining in tissue sections (PMC12561060; PMC11904056; PMC10552693).
| Sample | Paraffin-embedded human thyroid cancer tissue; fixative not specified (datasheet A02644-2) |
| Fixation | Image fixative and duration unreported (datasheet A02644-2); verify before use. |
| Sectioning | 4–5 µm sections on charged slides (standard) |
| Deparaffinisation | Xylene, graded ethanol series to water (standard) |
| Antigen retrieval | Heat retrieval: EDTA pH 8.0 (datasheet A02644-2); 20 min, 95–100 °C (standard) |
| Peroxidase block | 3% H2O2, 10 min, room temperature (standard) |
| Blocking | 10% goat serum (datasheet A02644-2) |
| Primary antibody | Rabbit anti-JCHAIN, 2-5 μg/ml (datasheet A02644-2) |
| Primary incubation | Overnight at 4 °C (datasheet A02644-2) |
| Detection | HRP-conjugated secondary, DAB chromogen (datasheet A02644-2) |
| Counterstain | Hematoxylin, blue, dehydrate and mount (standard) |
| Expected result | JCHAIN-positive staining in endocrine cells of appendix (HPA tissue IHC: High). HPA tissue profile: Cytoplasmic expression in several tissues, most abundant in gastrointestinal tract and lymphoid tissues. Additional plasma positivity. No signal in the no-primary control. |
💡Decision noteStart with heat-mediated EDTA at pH 8.0 for the catalog antibody (datasheet A02644-2); published protocols used citrate retrieval with other antibodies (PMC12561060; PMC10552693).
Section 2
What Is the Expected JCHAIN Staining Pattern?
JCHAIN is secreted and has no transmembrane segment (UniProt P01591: subcellular location and topology). On paraffin sections, expect predominantly cytoplasmic staining, with additional plasma positivity (HPA: tissue IHC profile). Staining is most abundant in gastrointestinal and lymphoid tissues; reported High cell populations include intestinal enterocytes, appendix and rectal endocrine cells, breast glandular cells, and lung macrophages (HPA: tissue IHC, Enhanced reliability).
| Distinct cytoplasmic chromogen in colon or duodenal enterocytes, with a readable counterstain. | This matches an HPA High cell population and the reported cytoplasmic profile (HPA: colon and duodenum tissue IHC). Compare cells within the section: a positive call should rest on identifiable stained cells, not overall brown color. Additional plasma positivity can occur (HPA: tissue IHC profile). |
| A sharply nuclear or continuous cell-border pattern dominates the positive cells. | Treat this as a localization mismatch: HPA reports cytoplasmic expression, while UniProt describes a secreted protein without a transmembrane segment (HPA: tissue IHC profile; UniProt P01591: topology). Review morphology, counterstain, and detection controls before attributing that compartmental pattern to JCHAIN (general IHC practice). |
| Strong chromogen appears in adipocytes or adrenal glandular cells. | HPA lists both cell populations as Not detected (HPA: adipose tissue and adrenal gland tissue IHC). A discrepant result warrants a check for cross-reactivity or endogenous detection activity; it alone cannot identify the cause (general IHC practice). Assess whether staining follows cell boundaries or appears as nonspecific deposits. |
| A diffuse brown haze covers stroma, empty spaces, and many unrelated cell types. | This is difficult to reconcile with the reported cell-associated cytoplasmic pattern, although HPA also notes plasma positivity for this secreted protein (HPA: tissue IHC profile; UniProt P01591: subcellular location). Compare a no-primary control and inspect washes, blocking, and chromogen development as general IHC checks; do not score haze as positive cells. |
| No convincing signal appears in an adequately sampled colon section. | Colon enterocytes are reported High, so absent staining makes this run uninformative until technical failure and tissue identification are checked (HPA: colon tissue IHC). Check the antibody's IHC-P instructions and the run controls; HPA tissue data do not establish a JCHAIN-specific retrieval, fixation, or dilution requirement (general IHC practice). |
💡Expected JCHAIN appearanceCall the result positive when identifiable gastrointestinal enterocytes or another HPA-reported positive cell population shows clear cytoplasmic staining, potentially High in listed populations; isolated nuclear or uniform pan-tissue staining is suspect (HPA: tissue IHC profile and listed cell levels; UniProt P01591: secreted topology).
| Cell population and tissue selection | HPA reports High staining in colon, duodenal, and small-intestinal enterocytes, but Not detected staining in adipocytes; choose controls by the named cell population, not tissue label alone (HPA: tissue IHC). |
| Secretion and compartment | JCHAIN lacks a transmembrane segment and participates in secretory IgA and IgM complexes (UniProt P01591: topology and subunit). Cytoplasmic staining plus additional plasma positivity is reported; extracellular color needs morphological context (HPA: tissue IHC profile). |
| Protein processing | UniProt records a signal peptide at residues 1–22 and a mature chain at 23–159 (UniProt P01591: processing). The payload gives no antibody epitope, so processing cannot predict this antibody's staining intensity or a retrieval condition. |
| Evidence and validation scope | HPA rates tissue IHC reliability Enhanced and lists Enhanced IHC status for HPA044132 and CAB034436 (HPA: tissue IHC and antibodies). Its note says secreted proteins may have different RNA and protein locations; RNA enrichment is not a cell-level staining map (HPA: reliability note and RNA specificity). |
| IF/ICC evidence | HPA summarizes JCHAIN as secreted but provides no main ICC-IF location or cell-line images (HPA: subcellular record). That evidence cannot establish a specific IF compartment or serve as an IF protocol; evaluate IF/ICC on its separate guide page. |
| Situation | Likely cause | Next action |
|---|---|---|
| Positive-control colon enterocytes are unstained. | A run or specimen problem is plausible because HPA reports High staining in these cells (HPA: colon tissue IHC). The supplied sources do not assign a JCHAIN-specific failure mechanism. | Confirm enterocytes are present, review the IHC-P antibody instructions, and check detection and run controls (general IHC practice). Record any retrieval change as empirical; no target-specific fixation or retrieval sensitivity is supplied. |
| Only weak staining appears in a candidate positive section. | Expected levels differ by cell population: bone marrow hematopoietic cells are Medium, whereas listed intestinal enterocytes are High (HPA: tissue IHC). Weak color alone cannot separate biology from a technical issue. | Compare matched cell populations and an HPA-listed High control in the same run (HPA: tissue IHC). Then review antibody dilution and detection against the catalog IHC-P instructions (general IHC practice). |
| Adipocytes or adrenal glandular cells look strongly positive. | Those populations are listed Not detected; cross-reactivity or endogenous detection activity is possible, but the image alone cannot distinguish them (HPA: tissue IHC; general IHC practice). | Run a no-primary control and inspect the pattern for deposits or broad background; review endogenous activity blocking for the detection chemistry used (general IHC practice). Keep the result provisional until controls resolve the discrepancy. |
| Staining is nuclear or outlines most cell membranes. | That dominant pattern conflicts with HPA's cytoplasmic profile and the UniProt secreted, non-transmembrane annotation (HPA: tissue IHC profile; UniProt P01591: topology). It is a warning sign rather than proof of one artefact. | Check counterstain and tissue morphology, compare the positive control, and examine a no-primary control (general IHC practice). Report the unusual compartment separately instead of scoring it as the expected JCHAIN pattern. |
| Brown haze obscures otherwise identifiable cells. | Diffuse background can result from detection or wash conditions in chromogenic IHC (general IHC practice). Some plasma positivity is reported for JCHAIN, so extracellular color by itself does not prove nonspecific staining (HPA: tissue IHC profile). | Compare no-primary and positive controls; review blocking, washing, and chromogen development (general IHC practice). Score only localized staining that can be assigned confidently to the relevant cells. |
| Can the IHC pattern be used as an IF/ICC localization prediction? | HPA has no ICC-IF cell-line images and gives no main subcellular location beyond a secreted summary (HPA: subcellular record). Its tissue IHC profile describes chromogenic tissue staining, not an IF validation. | Use the separate IF/ICC guide for that application. If interpreting an IF image, require its own controls and cell-level evidence before assigning a compartment (general IF practice); do not treat this IHC pattern as an IF protocol. |
Experiment evidence
IHC & IF images showing JCHAIN staining
A02644-2 · IHCIHC analysis of JCHAIN using anti-JCHAIN antibody (A02644-2). JCHAIN was detected in a paraffin-embedded section of human thyroid cancer tis
A02644-2 · IHCIHC analysis of JCHAIN using anti-JCHAIN antibody (A02644-2). JCHAIN was detected in a paraffin-embedded section of human liver cancer tissu
A02644-2 · IFIF analysis of JCHAIN using anti-JCHAIN antibody (A02644-2). JCHAIN was detected in an immunocytochemical section of U2OS cells. Enzyme anti
HPA · Cerebral cortexHuman Protein Atlas IHC, Cerebral cortex. Source: https://www.proteinatlas.org/ENSG00000132465-JCHAIN/tissue/cerebral+cortex#imid_8865700
HPA · ColonHuman Protein Atlas IHC, Colon. Source: https://www.proteinatlas.org/ENSG00000132465-JCHAIN/tissue/colon#imid_8865610
HPA · LiverHuman Protein Atlas IHC, Liver. Source: https://www.proteinatlas.org/ENSG00000132465-JCHAIN/tissue/liver#imid_8865627
HPA · KidneyHuman Protein Atlas IHC, Kidney. Source: https://www.proteinatlas.org/ENSG00000132465-JCHAIN/tissue/kidney#imid_8865620
← swipe / scroll for more images →
Real IHC / IF data behind the staining-pattern expectations in this section.
Sample controls for JCHAIN IHC & IF
🧪Run colon first and score enterocytes, which HPA rates High for JCHAIN staining (HPA: High in colon enterocytes). Use adipose tissue as the negative comparator, where adipocytes are Not detected (HPA: Not detected in adipocytes); on the colon slide, use morphologically unstained cells outside the enterocyte compartment as an internal background reference rather than assuming every other cell type is negative (HPA: High in colon enterocytes).
Positive control tissue: Appendix (Endocrine cells, HPA High)
Negative control tissue: Adipose tissue (HPA Not detected)
ICC-IF cell lines (HPA subcellular resource): HPA carries no ICC-IF cell line for JCHAIN; derive a cell-line control from the positive tissue's cell type (Endocrine cells) and confirm it by RNA or western blot first.
Technical controls: Include a no-primary, secondary-only control and a host-matched rabbit IgG isotype control for the rabbit catalog antibody (selected-SKU caption: rabbit anti-JCHAIN; standard IHC practice). Where a validated reagent is available, use cognate-peptide blocking as a biological specificity check; quench endogenous peroxidase before HRP/DAB detection in colon (selected-SKU caption: HRP/DAB; standard IHC practice).
⚠️Feasibility: A target-specific fixation window or fixation effect is unreported, and the selected-SKU paraffin-section caption does not state its fixative (selected-SKU caption: fixative not stated). The documented IHC-P example uses heat retrieval in EDTA at pH 8.0, so that is a supported starting condition, though retrieval dependence has not been established (selected-SKU caption: EDTA pH 8.0). Frozen sections and IF/ICC have no comparative evidence in the supplied sources; in colon, distinguish cellular staining from luminal secretions because JCHAIN is secreted and participates in secretory IgA (HPA: High in colon enterocytes; UniProt P01591: Secreted, secretory IgA complex).
HPA tissue IHC evidence for JCHAIN
Comprehensive Human Protein Atlas IHC scoring per tissue (reliability: Enhanced — High consistency between antibody staining and RNA expression data. Secreted protein, tissue location of RNA and protein is expected to differ.). Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
Positive expression · recommended positive controls
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Appendix | Endocrine cells | High | Protein (IHC) | HPA → |
| Breast | Glandular cells | High | Protein (IHC) | HPA → |
| Colon | Enterocytes | High | Protein (IHC) | HPA → |
| Duodenum | Enterocytes | High | Protein (IHC) | HPA → |
| Lung | Macrophages | High | Protein (IHC) | HPA → |
Undetected expression · recommended negative controls
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adipose tissue | Adipocytes | Not detected | Protein (IHC) | HPA → |
| Adrenal gland | Glandular cells | Not detected | Protein (IHC) | HPA → |
| Caudate | Glial cells | Not detected | Protein (IHC) | HPA → |
| Cerebellum | Cells in granular layer | Not detected | Protein (IHC) | HPA → |
| Cerebral cortex | Endothelial cells | Not detected | Protein (IHC) | HPA → |
Section 3
Advanced JCHAIN IHC Tips
Troubleshoot JCHAIN chromogenic IHC by checking retrieval, cellular and extracellular staining, background, and scoring against the supplied tissue evidence.
Which retrieval conditions should I start with for JCHAIN in paraffin sections?
Begin with heat-mediated retrieval in EDTA, pH 8.0, for sections stained with A02644-2 (datasheet A02644-2). The selected image used this retrieval with 2 μg/ml primary antibody overnight at 4°C (caption A02644-2). Assess cellular and extracellular signal separately because JCHAIN is secreted and HPA reports cytoplasmic staining with additional plasma positivity (UniProt P01591; HPA tissue IHC). If staining is weak, vary heating duration while keeping the buffer, antibody concentration, and detection method constant (standard IHC practice). Compare tissue morphology and section adhesion as well as staining intensity when choosing a retrieval condition (standard IHC practice).
How should I troubleshoot weak staining when fixation history is uncertain?
The selected JCHAIN image identifies a paraffin section but does not state its fixative, so target-specific fixation sensitivity is unknown (caption A02644-2). Record the fixative and fixation duration for each specimen, and compare sections processed together when investigating weak signal (standard IHC practice). Start with the documented EDTA, pH 8.0 retrieval before changing detection conditions (datasheet A02644-2). If processing histories differ, inspect morphology and compare staining within each processing group before attributing differences to JCHAIN abundance (standard IHC practice). HPA tissue staining cannot establish how this antibody responds to different fixatives (HPA tissue IHC).
Where should convincing JCHAIN staining appear in a tissue section?
Expect a cellular cytoplasmic pattern and assess any plasma staining separately, as reported for JCHAIN tissue IHC (HPA tissue IHC). JCHAIN is secreted and has no transmembrane segment, so a sharply membrane-restricted pattern warrants closer review (UniProt P01591 topology and subcellular annotation). HPA reports abundant staining in gastrointestinal tract and lymphoid tissues, with high staining in colon enterocytes and lung macrophages (HPA tissue IHC). Use tissue architecture and cell identity to distinguish staining of cells from nearby extracellular signal (standard IHC practice). Compare these compartments on serial sections when an apparent shift in localisation accompanies a processing change (standard IHC practice).
Could JCHAIN processing or epitope position explain discordant staining?
JCHAIN has 0 annotated isoforms, so an isoform-specific explanation is unsupported by this record (UniProt P01591). Its precursor is 159 amino acids; the signal peptide spans residues 1–22 and the mature chain spans 23–159 (UniProt P01591 processing). Residue 71 is a glycosylation site, and residue 23 has an annotated modification (UniProt P01591). The supplied evidence does not map this antibody's epitope, so do not assign weak staining to either site (datasheet A02644-2; UniProt P01591). Compare retrieval conditions and staining controls before proposing an epitope-level mechanism (standard IHC practice).
How can I assess JCHAIN by multiplex IF alongside chromogenic IHC?
Treat IF as a separate assay: the supplied product image documents chromogenic staining of a paraffin section, while HPA provides no cell-line ICC/IF images (caption A02644-2; HPA subcellular). Pair JCHAIN with a validated marker for the cell population under study, such as an enterocyte marker when examining intestinal sections (HPA tissue IHC; standard IF practice). Choose fluorophores after inspecting unstained tissue for autofluorescence, and include single-color controls to assess channel bleed-through (standard IF practice). Select permeabilisation for an intracellular epitope only after checking antibody epitope information; JCHAIN is secreted and lacks a transmembrane segment (UniProt P01591). Score cellular and extracellular fluorescence separately (HPA tissue IHC).
What should I check when JCHAIN DAB staining is diffuse?
The selected image used an anti-rabbit secondary and DAB development, so first compare stained sections with appropriate secondary-only controls (caption A02644-2; standard IHC practice). Quench endogenous peroxidase and optimise serum or protein blocking when background obscures cell boundaries (standard IHC practice). The documented section received 10% goat serum blocking and 2 μg/ml primary antibody overnight at 4°C (caption A02644-2). Evaluate true extracellular signal cautiously because JCHAIN is secreted and HPA reports additional plasma positivity (UniProt P01591; HPA tissue IHC). Check tissue edges, damaged areas, and control sections before treating diffuse DAB as specific expression (standard IHC practice).
How should I score heterogeneous JCHAIN staining across a section? ⚠ ANSWER MARKED FOR VERIFICATION
Define the compartment and cell population before scoring because HPA describes cytoplasmic expression plus additional plasma positivity (HPA tissue IHC). For cellular staining, record the percentage of positive cells and intensity, then calculate an H-score if intensity categories are reproducible (standard IHC practice). For sparse positive cells, report positive-cell density per mm² of viable, evaluable tissue (standard IHC practice). Normalise cell counts to the relevant cell population or tissue area, and report extracellular staining as a separate measure (standard IHC practice). Use the same threshold, section sampling rule, and imaging settings across comparison groups (standard IHC practice).
How do I separate true JCHAIN signal from staining artefact?
Interpret a positive result through its pattern and cell identity: HPA reports cytoplasmic expression, additional plasma positivity, and high staining in colon enterocytes and lung macrophages (HPA tissue IHC). A solely membrane-restricted pattern needs scrutiny because JCHAIN is secreted and has no transmembrane segment (UniProt P01591). Compare suspect signal with tissue edges and necrotic areas, where nonspecific chromogen accumulation can complicate interpretation (standard IHC practice). Check a secondary-only control and adequate peroxidase blocking when diffuse brown signal raises concern for detection background (standard IHC practice). HPA lists adipocytes as not detected, providing a tissue-context comparison rather than a universal negative control (HPA tissue IHC).
Boster reagents
Best JCHAIN / Immunoglobulin J chain IHC Antibodies
A02644-2 has IHC images from paraffin sections of human thyroid cancer, human liver cancer and rat colon, plus an IF image from U2OS cells (catalog image captions).
Real IHC data
Anti-JCHAIN Antibody ®
Cat # A02644-2
A02644-2 is listed for IHC and shows staining in paraffin sections of human thyroid cancer, human liver cancer and rat colon (catalog applications; IHC image captions). A02644-2 is also listed for IF/ICC and shows IF staining in U2OS cells (catalog applications; IF image caption).
Which to pick: Choose A02644-2 for paraffin-section IHC: its thyroid cancer image documents EDTA retrieval at pH 8.0 and a primary antibody concentration of 2 μg/ml; the fixative is unreported (A02644-2 IHC image caption). For IF/ICC, A02644-2 has a U2OS cell image using 5 μg/ml primary antibody (A02644-2 IF image caption). For work across species, A02644-2 lists human, mouse and rat reactivity, with IHC images for human and rat; it is rabbit hosted, and clonality is unreported (catalog reactivity, host and clone fields; IHC image captions).
Each figure is that product's own IHC / IF validation image from its datasheet.
References
- UniProt Consortium. UniProt entry P01591 (IGJ_HUMAN, Immunoglobulin J chain).
- Human Protein Atlas. JCHAIN tissue IHC expression (reliability: Enhanced).
- Human Protein Atlas. JCHAIN subcellular location (ICC-IF): Secreted.
- Human Protein Atlas. JCHAIN antibody validation summary (2 antibodies).
- Comprehensive Analysis of JCHAIN as a Potential Prognostic Factor for Breast Cancer and an Indicator for Tumor Microenvironment. Biomedicines 2025 — PMC12561060.
- JCHAIN: A Prognostic Marker Based on Pan-Cancer Analysis to Inhibit Breast Cancer Progression. Genes 2025 — PMC12469470.
- Transcription factor networks and novel immune biomarkers reveal key prognostic and therapeutic insights in ovarian cancer. Discover oncology 2025 — PMC11904056.
- IGJ suppresses breast cancer growth and metastasis by inhibiting EMT via the NF‑κB signaling pathway. International journal of oncology 2023 — PMC10552693.
- PubMed PMID:14702039 — UniProt-cited evidence.
- PubMed PMID:407930 — UniProt-cited evidence.
- PubMed PMID:2984306 — UniProt-cited evidence.
Immunohistochemistry protocol sheet for JCHAIN (Immunoglobulin J chain). Expected localisation Cytoplasmic staining; additional plasma positivity (HPA tissue IHC). Antigen retrieval: EDTA pH 8.0 HIER, heat-mediated (datasheet A02644-2). Validated IHC antibody: A02644-2 at 2-5 μg/ml (the product's own IHC validation image is shown). Controls (HPA): positive Appendix (Endocrine cells); negative Adipose tissue. IHC-P workflow on paraffin sections; fixative unspecified. Protocol steps: 1. Sample: Paraffin-embedded human thyroid cancer tissue; fixative not specified (datasheet A02644-2); 2. Fixation: Image fixative and duration unreported (datasheet A02644-2); verify before use.; 3. Sectioning: 4–5 µm sections on charged slides (standard); 4. Deparaffinisation: Xylene, graded ethanol series to water (standard); 5. Antigen retrieval: Heat retrieval: EDTA pH 8.0 (datasheet A02644-2); 20 min, 95–100 °C (standard); 6. Peroxidase block: 3% H2O2, 10 min , room temperature (standard); 7. Blocking: 10% goat serum (datasheet A02644-2); 8. Primary antibody: Rabbit anti-JCHAIN, 2-5 μg/ml (datasheet A02644-2); 9. Primary incubation: Overnight at 4 °C (datasheet A02644-2). Watch for: Fixation: Keep paraffin-section fixation consistent (standard IHC practice; not target-specific); Caveat: As a secreted protein, RNA and protein locations may differ (HPA tissue IHC); Isoform / epitope: 0 annotated isoforms; signal peptide is cleaved (UniProt); Regulation: Expression regulation not annotated (UniProt). Evidence: UniProt P01591, HPA tissue IHC · Enhanced, HPA ICC-IF · Secreted, Datasheet A02644-2, PMC12561060, PMC11904056. QR code links to https://www.bosterbio.com/bosterbio-gene-info-cards/JCHAIN/immunohistochemistry-ihc-guide.